X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (415) 415
Patent (29) 29
Publication (15) 15
Book Chapter (9) 9
Book / eBook (1) 1
Book Review (1) 1
Dissertation (1) 1
Reference (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (222) 222
male (106) 106
female (91) 91
immunology (88) 88
adult (83) 83
animals (74) 74
cytokines (66) 66
index medicus (59) 59
middle aged (57) 57
antibodies (39) 39
mice (33) 33
adolescent (31) 31
aged (31) 31
cells, cultured (28) 28
infliximab (28) 28
tumor-necrosis-factor (28) 28
investigating or analysing materials by determining theirchemical or physical properties (25) 25
measuring (25) 25
physics (25) 25
testing (25) 25
inflammation (24) 24
therapy (23) 23
antibodies, monoclonal - therapeutic use (22) 22
enzyme-linked immunosorbent assay (22) 22
immunogenicity (22) 22
rats (22) 22
time factors (22) 22
expression (21) 21
interleukin-1 - pharmacology (21) 21
rheumatoid-arthritis (21) 21
cell biology (20) 20
interleukin-1 (20) 20
tumor necrosis factor-alpha - antagonists & inhibitors (20) 20
autoantibodies (19) 19
disease (19) 19
multiple sclerosis (19) 19
treatment outcome (19) 19
young adult (19) 19
biochemistry & molecular biology (18) 18
interferon-gamma (18) 18
rheumatoid arthritis (18) 18
interleukins (17) 17
islets of langerhans - drug effects (17) 17
microbiology (17) 17
pharmacology & pharmacy (17) 17
rheumatology (17) 17
t-lymphocytes - immunology (17) 17
gastroenterology & hepatology (16) 16
lymphocyte activation (16) 16
tumor necrosis factor (16) 16
tumor necrosis factor-alpha - metabolism (16) 16
adalimumab (15) 15
crohns-disease (15) 15
insulin - metabolism (15) 15
islets of langerhans - metabolism (15) 15
crohn disease - drug therapy (14) 14
crohn's disease (14) 14
cytokines - biosynthesis (14) 14
cytokines - blood (14) 14
cytokines - immunology (14) 14
pharmacokinetics (14) 14
research (14) 14
antibodies - blood (13) 13
antibodies, monoclonal - immunology (13) 13
autoimmunity (13) 13
cells (13) 13
clinical neurology (13) 13
human necessities (13) 13
hygiene (13) 13
inflammatory bowel disease (13) 13
inflammatory-bowel-disease (13) 13
interferon (13) 13
medical or veterinary science (13) 13
preparations for medical, dental, or toilet purposes (13) 13
t cells (13) 13
analysis (12) 12
arthritis, rheumatoid - drug therapy (12) 12
bioavailability (12) 12
cytokine (12) 12
interferon-beta - immunology (12) 12
interleukin-6 (12) 12
research article (12) 12
tumor necrosis factor-alpha - biosynthesis (12) 12
tumor necrosis factor-alpha - immunology (12) 12
tumor necrosis factor-alpha - pharmacology (12) 12
anti-inflammatory agents - therapeutic use (11) 11
antibodies - immunology (11) 11
autoantibodies - blood (11) 11
autoantibodies - immunology (11) 11
child (11) 11
dentistry, oral surgery & medicine (11) 11
efficacy (11) 11
gastroenterology and hepatology (11) 11
insulin secretion (11) 11
interleukin-6 - immunology (11) 11
leukocytes, mononuclear - drug effects (11) 11
monocytes (11) 11
monocytes - immunology (11) 11
prospective studies (11) 11
recombinant proteins - pharmacology (11) 11
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Frontiers in Immunology, ISSN 1664-3224, 2015, Volume 6, p. 152
Specific inhibition of the cytokine, tumor necrosis factor-alpha (TNF), has revolutionized the treatment of patients with several autoimmune diseases, and... 
Individualized medicine | Pharmacodynamics | Immunogenicity | Anti-drug antibodies | Pharmacokinetics | Anti-TNF-α biopharmaceuticals | Theranostics | anti-drug antibodies | pharmacodynamics | individualized medicine | DISEASE | pharmacokinetics | theranostics | anti-TNF-alpha biopharmaceuticals | IMMUNOLOGY | INFLIXIMAB | immunogenicity | BIOAVAILABILITY
Journal Article
Gut, ISSN 0017-5749, 06/2014, Volume 63, Issue 6, pp. 919 - 927
Journal Article
Journal of Interferon & Cytokine Research, ISSN 1079-9907, 10/2010, Volume 30, Issue 10, p. 759
  This review discusses type I interferon (IFN) immunogenicity with focus on methods of detection of anti-IFN antibodies in patients treated with human... 
Monoclonal antibodies | Multiple sclerosis | Care and treatment | Research | Health aspects | Interferon beta
Journal Article
Neurology, ISSN 0028-3878, 11/2003, Volume 61, Issue 9, p. S10
Journal Article
Immunotherapy, ISSN 1750-743X, 11/2012, Volume 4, Issue 11, p. 1167
  This article discusses the rationale behind recommending immunopharmacological guidance of long-term therapies with genetically engineered... 
Proteins | Disease | Rheumatoid arthritis | Eye diseases | Drug therapy | Pharmaceutical industry | Drug dosages | Failure
Journal Article
International Journal of Cancer, ISSN 0020-7136, 04/2017, Volume 140, Issue 8, pp. 1713 - 1726
Journal Article
Journal Article
Inflammatory Bowel Diseases, ISSN 1078-0998, 05/2016, Volume 22, Issue 8, pp. 1999 - 2015
Background:Biological tumor necrosis factor (TNF) inhibitors have revolutionized the treatment of inflammatory bowel disease and redefined treatment goals to... 
certolizumab pegol | TNF inhibitor | infliximab | Crohn's disease | adalimumab | golimumab | inflammatory bowel disease | antibodies | pharmacodynamic | ulcerative colitis | pharmacokinetic | loss of response | therapeutic drug monitoring | personalized therapy | NECROSIS-FACTOR ANTAGONISTS | THERAPEUTIC MONOCLONAL-ANTIBODIES | INFLIXIMAB TREATMENT FAILURE | REGULATORY T-CELLS | C-REACTIVE PROTEIN | RHEUMATOID-ARTHRITIS PATIENTS | MANAGING SECONDARY LOSS | FACTOR-ALPHA ANTAGONISTS | PLACEBO-CONTROLLED TRIALS | ACTIVE ULCERATIVE-COLITIS | GASTROENTEROLOGY & HEPATOLOGY | Humans | Immunosuppressive Agents - pharmacokinetics | Immunosuppressive Agents - therapeutic use | Antibodies, Monoclonal - therapeutic use | Infliximab - therapeutic use | Infliximab - pharmacokinetics | Antibodies, Monoclonal - blood | Immunosuppressive Agents - blood | Adalimumab - blood | Treatment Failure | Adalimumab - pharmacokinetics | Certolizumab Pegol - pharmacokinetics | Certolizumab Pegol - therapeutic use | Infliximab - blood | Antibodies, Monoclonal - immunology | Certolizumab Pegol - blood | Certolizumab Pegol - immunology | Inflammatory Bowel Diseases - drug therapy | Adalimumab - immunology | Antibodies, Monoclonal - pharmacokinetics | Infliximab - immunology | Adalimumab - therapeutic use | Immunosuppressive Agents - immunology | Antibodies - blood | Drug Monitoring | Tumor Necrosis Factor-alpha - antagonists & inhibitors
Journal Article